Skip to content

4Accepted Jun 9, 8:54 PM ET

FitzPatrick Margaret M 4

ANTXAN2 Therapeutics, Inc.

Accepted (ET)

8:54 PM

Jun 9, 2023

Filed

Jun 9, 2023

Documents

2

Size

9.2 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.